(Total Views: 66)
Posted On: 09/17/2019 11:30:43 AM
Post# of 47159

$GALT News Article - Galectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer Immunotherapy https://marketwirenews.com/news-releases/gale...87019.html


My Twitter: WhyteStocks